Efficacy of a nurse-led patient education intervention in promoting safety skills of patients with inflammatory arthritis treated with biologics: a multicentre randomised clinical trial

• DOI: 10.1136/rmdopen-2021-001828
• Publication Date: 2022-03-16T16:12:56Z
• Authors: Catherine Beauvais; Françoise Fayet; Alexandra Rousseau; Christelle Sordet; Sophie Pouplin; Yves Maugars; Rose Marie Poilverd; Carine Savel; Véronique Ségard; Béatrice Godon; Christian L’amour; Aleth Perdriger; Fabienne Brin; Patricia Peyrard; Fabienne Chalier; Béatrice Pallot-P...; Sophie Tuffet; Isabelle Griffoul; Laure Gossec
• Keywords: Biological Products; [SDV]Life Sciences [q-bio]; R; 610; patient care team; Nurse's Role; Education; 3. Good health; [SDV] Life Sciences [q-bio]; Arthritis, Rheumatoid; 03 medical and health sciences; 0302 clinical medicine; arthritis; nursing; Patient Education as Topic; biological therapy; Antirheumatic Agents; Medicine; Humans

ObjectiveTo evaluate the effect of a nurse-led patient education on safety skills of patients with inflammatory arthritis treated with biologic disease-modifying antirheumatic drugs (bDMARDs).MethodsThis is a multicentre, open-labelled, randomised controlled trial comparing an intervention group (face-to-face education by a nurse at baseline and 3 months later) with a control group (usual care) at the introduction of a first subcutaneous bDMARD. The primary outcome was score on the BioSecure questionnaire at 6 months (0–100 scale), a validated questionnaire assessing competencies in dealing with fever, infections, vaccination and daily situations. The secondary outcomes were disease activity, coping, psychological well-being, beliefs about medication, self-efficacy and severe infection rate.Results129 patients with rheumatoid arthritis and spondyloarthritis were enrolled in nine rheumatology departments; 122 completed the study; 127 were analysed; and 64 received the intervention (mean duration: 65 min at baseline and 44 min at 3 months). The primary outcome was met: the BioSecure score was 81.2±13.1 and 75.6±13.0 in the education and usual care groups (difference: +6.2, 95% CI 1.3 to 11.1, p=0.015), demonstrating higher safety skills in the education group. Exploratory analyses showed better skills regarding infections, greater willingness for vaccinations and greater adherence-related behaviours in the education group. Coping was significantly more improved by education; other secondary outcomes were improved in both groups, with no difference.ConclusionsEducating patients was effective in promoting patient behaviours for preventing adverse events with bDMARDs. An education session delivered to patients starting a first bDMARD can be useful to help them self-manage safety issues.Trial registration numberNCT02855320.